<?xml version='1.0' encoding='utf-8'?>
<document id="3107168"><sentence text="Clinically significant danazol-carbamazepine interaction."><entity charOffset="23-44" id="DDI-PubMed.3107168.s1.e0" text="danazol-carbamazepine" /></sentence><sentence text="In six patients with epilepsy and fibrocystic breast disease the concentration in serum of antiepileptic drugs was obtained before, during, and after danazol therapy"><entity charOffset="150-157" id="DDI-PubMed.3107168.s2.e0" text="danazol" /></sentence><sentence text=" Carbamazepine serum levels increased almost twofold in the presence of danazol"><entity charOffset="1-14" id="DDI-PubMed.3107168.s3.e0" text="Carbamazepine" /><entity charOffset="72-79" id="DDI-PubMed.3107168.s3.e1" text="danazol" /><pair ddi="false" e1="DDI-PubMed.3107168.s3.e0" e2="DDI-PubMed.3107168.s3.e0" /><pair ddi="false" e1="DDI-PubMed.3107168.s3.e0" e2="DDI-PubMed.3107168.s3.e1" /></sentence><sentence text=" Thus, interaction between carbamazepine and danazol producing acute carbamazepine toxicity is clinically significant"><entity charOffset="27-40" id="DDI-PubMed.3107168.s4.e0" text="carbamazepine" /><entity charOffset="45-52" id="DDI-PubMed.3107168.s4.e1" text="danazol" /><entity charOffset="69-82" id="DDI-PubMed.3107168.s4.e2" text="carbamazepine" /><pair ddi="false" e1="DDI-PubMed.3107168.s4.e0" e2="DDI-PubMed.3107168.s4.e0" /><pair ddi="false" e1="DDI-PubMed.3107168.s4.e0" e2="DDI-PubMed.3107168.s4.e1" /><pair ddi="false" e1="DDI-PubMed.3107168.s4.e0" e2="DDI-PubMed.3107168.s4.e2" /><pair ddi="false" e1="DDI-PubMed.3107168.s4.e1" e2="DDI-PubMed.3107168.s4.e1" /><pair ddi="false" e1="DDI-PubMed.3107168.s4.e1" e2="DDI-PubMed.3107168.s4.e2" /></sentence><sentence text=" If these drugs are administered concurrently, an awareness of the potential for this drug-drug interaction along with monitoring of carbamazepine levels is required for optimal patient care"><entity charOffset="133-146" id="DDI-PubMed.3107168.s5.e0" text="carbamazepine" /></sentence><sentence text="" /></document>